Hong Kong REITS Stock News

SEHK:1768
SEHK:1768Consumer Retailing

Asian Market Stocks That May Be Trading Below Their Estimated Value

Amidst ongoing geopolitical tensions and energy market volatility, Asian markets have been navigating a complex landscape, with indices showing mixed performances as investors assess the impact of these global events. In such an environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on market inefficiencies.
SEHK:6618
SEHK:6618Consumer Retailing

How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors

On March 20, 2026, CF PharmTech, Inc. announced a cooperation under which JD Health International will be the exclusive online launch platform for several major new respiratory and rhinology products over the next three years, while also exploring internet-based chronic disease management models together. Alongside this, JD Health’s recent grant of 834,412 new share awards with strict clawback terms and its deeper role in digital drug commercialization highlight how the company is tying...
SEHK:2595
SEHK:2595Biotechs

3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 46.6%

Amidst ongoing geopolitical tensions and energy market volatility, Asian markets have displayed mixed performance, with investors navigating both regional challenges and opportunities. In this environment, identifying undervalued stocks can be a strategic approach for investors seeking potential value plays, especially when these stocks are trading at significant discounts relative to their intrinsic worth.
SEHK:1361
SEHK:1361Luxury

Why 361 Degrees (SEHK:1361) Is Up 14.8% After FY2025 Earnings Beat And Dividend Proposal

361 Degrees International has reported its full-year 2025 results, with sales rising to CNY 11,145.83 million and net income reaching CNY 1,308.88 million, alongside higher basic and diluted earnings per share of CNY 0.633. The board’s recommendation of a final dividend of HK$0.113 per share, subject to shareholder approval, underlines the company’s willingness to return cash to investors following this earnings performance. With revenue growth and a proposed final dividend on the table,...
SEHK:1093
SEHK:1093Pharmaceuticals

Is It Too Late To Consider CSPC Pharmaceutical Group (SEHK:1093) After Its 81% One-Year Rally?

If you are wondering whether CSPC Pharmaceutical Group at HK$9.71 is still reasonably priced after a strong run, the starting point is to understand how its current share price lines up with different measures of value. The stock has returned 19.0% over the past 7 days, 5.3% over the last month, 14.5% year to date and 80.6% over the past year, which naturally raises questions about how much potential or risk is now priced in. Recent coverage has focused on how investors are reassessing large...
SEHK:178
SEHK:178Specialty Retail

Asian Market Spotlight: Promising Penny Stocks For April 2026

As the Asian markets navigate through geopolitical tensions and energy market volatility, investors are keenly watching for opportunities that can weather these challenges. Penny stocks, though often seen as speculative, can offer unique growth potential when supported by strong financials. In this article, we explore several promising penny stocks in Asia that may combine value with long-term potential amidst current market conditions.